Passage Bio (PASG) Short Interest Ratio & Short Volume → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free PASG Stock Alerts $1.28 -0.04 (-3.03%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Passage Bio Short Interest DataCurrent Short Volume1,760,000 sharesPrevious Short Volume1,750,000 sharesChange Vs. Previous Month+0.57%Dollar Volume Sold Short$2.27 millionShort Interest Ratio / Days to Cover5.2Last Record DateApril 30, 2024Outstanding Shares61,610,000 sharesFloat Size41,140,000 sharesShort Percent of Float4.28%Today's Trading Volume70,979 sharesAverage Trading Volume318,785 sharesToday's Volume Vs. Average22% Short Selling Passage Bio ? Sign up to receive the latest short interest report for Passage Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPASG Short Interest Over TimePASG Days to Cover Over TimePASG Percentage of Float Shorted Over Time Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Passage Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,760,000 shares $2.27 million +0.6%4.3%5.2 $1.29 4/15/20241,750,000 shares $2.15 million +32.6%4.2%5.1 $1.23 3/31/20241,320,000 shares $1.78 million +9.1%3.6%3.4 $1.35 3/15/20241,210,000 shares $1.82 million +116.9%3.3%2.5 $1.50 2/29/2024557,800 shares $953,838.00 +122.0%1.5%0.9 $1.71 2/15/2024251,300 shares $331,716.00 -9.5%0.7%0.4 $1.32 Get the Latest News and Ratings for PASG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Passage Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024277,700 shares $272,146.00 -12.2%0.8%0.4 $0.98 1/15/2024316,300 shares $341,604.00 -17.6%0.9%0.5 $1.08 12/31/2023383,700 shares $387,537.00 +56.5%1.1%0.6 $1.01 12/15/2023245,200 shares $184,096.16 +1.5%0.7%0.4 $0.75 11/30/2023241,500 shares $152,410.65 -8.0%0.7%1 $0.63 11/15/2023262,400 shares $164,656.00 +14.9%0.7%1.3 $0.63 10/31/2023228,300 shares $146,112.00 -3.9%0.7%1.2 $0.64 10/15/2023237,500 shares $156,750.00 -4.7%0.7%1.5 $0.66 9/30/2023249,200 shares $163,973.60 +18.4%0.7%1.4 $0.66 9/15/2023210,500 shares $156,927.75 +5.3%0.6%1 $0.75 8/31/2023199,900 shares $156,121.90 -2.6%0.6%0.7 $0.78 8/15/2023205,300 shares $164,855.90 +13.0%0.6%0.7 $0.80 7/31/2023181,700 shares $160,077.70 -23.9%0.5%0.7 $0.88 7/15/2023238,900 shares $240,094.50 +8.1%0.8%1 $1.01 6/30/2023221,100 shares $208,121.43 -26.4%0.7%0.9 $0.94 6/15/2023300,400 shares $284,779.20 +11.8%1.0%1.4 $0.95 5/31/2023268,600 shares $255,438.60 +3.3%0.9%1.8 $0.95 5/15/2023260,100 shares $267,903.00 -10.5%0.9%1.7 $1.03 4/30/2023290,600 shares $302,224.00 -9.7%1.0%1.8 $1.04 4/15/2023321,800 shares $344,326.00 -12.7%1.1%2 $1.07 3/31/2023368,600 shares $353,008.22 +12.6%1.3%2.4 $0.96 3/15/2023327,400 shares $353,592.00 -2.2%1.1%2.1 $1.08 2/28/2023334,800 shares $411,804.00 +11.2%1.2%1.7 $1.23 2/15/2023301,200 shares $394,572.00 +4.7%1.0%1.5 $1.31 1/31/2023287,800 shares $420,188.00 -15.5%1.0%1.3 $1.46 1/15/2023340,600 shares $558,584.00 -8.0%1.2%1.5 $1.64 12/30/2022370,100 shares $510,738.00 -5.8%1.3%1.6 $1.38 12/15/2022392,700 shares $479,094.00 +18.6%1.4%1.7 $1.22 11/30/2022331,000 shares $403,820.00 -6.0%1.2%1.3 $1.22 11/15/2022352,100 shares $517,587.00 -15.4%1.2%1.4 $1.47 10/31/2022416,000 shares $507,520.00 -27.1%1.5%1.6 $1.22 10/15/2022570,900 shares $679,371.00 -21.1%2.1%2.1 $1.19 9/30/2022723,700 shares $904,625.00 -3.4%2.6%2.7 $1.25 9/15/2022748,800 shares $1.22 million -19.6%2.7%2.2 $1.63This unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company PASG Short Interest - Frequently Asked Questions What is Passage Bio's current short interest? Short interest is the volume of Passage Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,760,000 shares of PASG short. 4.28% of Passage Bio's shares are currently sold short. Learn More on Passage Bio's current short interest. What is a good short interest ratio for Passage Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PASG shares currently have a short interest ratio of 5.0. Learn More on Passage Bio's short interest ratio. What is a good short interest percentage for Passage Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.28% of Passage Bio's floating shares are currently sold short. Is Passage Bio's short interest increasing or decreasing? Passage Bio saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,760,000 shares, an increase of 0.6% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Passage Bio's float size? Passage Bio currently has issued a total of 61,610,000 shares. Some of Passage Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Passage Bio currently has a public float of 41,140,000 shares. How does Passage Bio's short interest compare to its competitors? 4.28% of Passage Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Passage Bio: Curis, Inc. (1.14%), AlloVir, Inc. (5.85%), Athira Pharma, Inc. (2.97%), Outlook Therapeutics, Inc. (7.65%), Gritstone bio, Inc. (15.43%), Elutia Inc. (0.20%), Precision BioSciences, Inc. (9.31%), Cognition Therapeutics, Inc. (0.56%), Instil Bio, Inc. (0.19%), Atara Biotherapeutics, Inc. (9.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Passage Bio stock? Short selling PASG is an investing strategy that aims to generate trading profit from Passage Bio as its price is falling. PASG shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Passage Bio? A short squeeze for Passage Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PASG, which in turn drives the price of the stock up even further. How often is Passage Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PASG, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CRIS Short Interest Data ALVR Short Interest Data ATHA Short Interest Data OTLK Short Interest Data GRTS Short Interest Data ELUT Short Interest Data DTIL Short Interest Data CGTX Short Interest Data TIL Short Interest Data ATRA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PASG) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsDems have chosen Biden replacement?Paradigm Press